Preference of DNA Methyltransferases for CpG Islands in Mouse Embryonic Stem Cells
- Naka Hattori1,
- Tetsuya Abe1,
- Naoko Hattori1,
- Masako Suzuki1,
- Tomoki Matsuyama2,
- Shigeo Yoshida2,
- En Li3,4, and
- Kunio Shiota1,5
- 1 Laboratory of Cellular Biochemistry, Animal Resource Sciences / Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan
- 2 Plant Functions Laboratory, RIKEN (The Institute of Physical and Chemical Research), Wako, Saitama 351-0198, Japan
- 3 Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
Abstract
Many CpG islands have tissue-dependent and differentially methylated regions (T-DMRs) in normal cells and tissues. To elucidate how DNA methyltransferases (Dnmts) participate in methylation of the genomic components, we investigated the genome-wide DNA methylation pattern of the T-DMRs with Dnmt1-, Dnmt3a-, and/or Dnmt3b-deficient ES cells by restriction landmark genomic scanning (RLGS). Approximately 1300 spots were detected in wild-type ES cells. In Dnmt1-/- ES cells, additional 236 spots emerged, indicating that the corresponding loci are methylated by Dnmt1 in wild-type ES cells. Intriguingly, in Dnmt3a-/-Dnmt3b-/- ES cells, the same 236 spots also emerged, and no additional spots appeared differentially. Therefore, Dnmt1 and Dnmt3a/3b share targets in CpG islands. Cloning and virtual image RLGS revealed that 81% of the RLGS spots were associated with genes, and 62% of the loci were in CpG islands. By contrast to the previous reports that demethylation at repeated sequences was severe in Dnmt1-/- cells compared with Dnmt3a-/-Dnmt3b-/- cells, a complete loss of methylation was observed at RLGS loci in Dnmt3a-/-Dnmt3b-/- cells, whereas methylation levels only decreased to 16% to 48% in the Dnmt1-/- cells. We concluded that there are CpG islands with T-DMR as targets shared by Dnmt1 and Dnmt3a/3b and that each Dnmt has target preferences depending on the genomic components.
Footnotes
-
Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.2431504. Article published online before print in August 2004.
-
↵4 Present address: Novartis Institute for Biomedical Research, Cambridge, MA 02139.
-
↵5 Corresponding author. E-MAIL ashiota{at}mail.ecc.u-tokyo.ac.jp; FAX 81-3-5841-8189.
-
- Accepted June 29, 2004.
- Received February 9, 2004.
- Cold Spring Harbor Laboratory Press











